Key result
Nonsyndromic CHD is linked to increased cancer risk, including ~12-fold higher lymphoma risk in aortic arch obstruction.
Why the study?
Prior studies linking congenital heart disease (CHD) with childhood cancer have not fully accounted for CHD's pathogenetic and clinical heterogeneity, limiting their clinical utility.
Does nonsyndromic congenital heart disease increase the risk of childhood cancer in children?
Cohort (n=11,000,000)
Yes
Does nonsyndromic congenital heart disease increase the risk of childhood cancer in children?
Hazard Ratio: 12.7 (95% CI 4.9–31)
While the absolute risk of cancer in children with nonsyndromic congenital heart disease is low (<1%), they have significantly increased relative hazards for specific malignancies such as hepatoblastoma, neuroblastoma, leukemia, and lymphoma.
These lesion-specific cancer associations should not yet alter practice; extends prior general links to targeted congenital heart disease subtypes in a large cohort.
BACKGROUND: Epidemiologic studies have demonstrated associations between congenital heart disease (CHD) and childhood cancer. However, these assessments have not fully accounted for the pathogenetic and clinical heterogeneity of CHD, limiting their capacity to inform pathogenetic studies and the clinical management of children with CHD. METHODS: To achieve a more detailed understanding of cancer risk in children with nonsyndromic CHD, we evaluated 60 cardiac lesions in 7 categories in a cohort of 11 million children from Massachusetts, North Carolina, Oklahoma, and Texas. We used Cox proportional hazards regression to estimate the hazard ratios (HRs) and 95% CIs of cancer in children with each lesion relative to children without congenital anomalies when there were ≥3 co-occurring cases. RESULTS: We identified 74 755 children with CHD and observed increased hazards for several malignancies. Notable associations included aortic arch obstruction-lymphoma (HR, 12.7 [95% CI, 4.9-31.0]); single-ventricle disease-lymphoma (HR, 9.7 [95% CI, 3.8-24.4]); complex atrioventricular septal defect-leukemia (HR, 8.05 [95% CI, 2.8-23.0]); ventricular septal defect-hepatoblastoma (HR, 11.2 [95% CI, 5.9-21.1]); and conotruncal defects-neuroblastoma (HR, 6.4 [95% CI, 1.9-22.2]). The cumulative incidence of cancer was <1% for all CHD groups evaluated. CONCLUSIONS: Cancer incidence in children with nonsyndromic CHD was generally low. However, we identified >5-fold increases in the hazard of hepatoblastoma, neuroblastoma, leukemia, and lymphoma in children with certain lesions. Our findings may assist in generating hypotheses about the causes of cancer in children with CHD.
No takes yet. Share an insight, caveat, or question.
Schraw et al. (2026) conducted a cohort in Nonsyndromic congenital heart disease (n=11,000,000). Nonsyndromic congenital heart disease vs. Children without congenital anomalies was evaluated on Lymphoma (in children with aortic arch obstruction) (HR 12.7, 95% CI 4.9-31.0). Nonsyndromic congenital heart disease was associated with increased cancer risk, including lymphoma in aortic arch obstruction (HR 12.7; 95% CI 4.9-31.0) and hepatoblastoma in VSD (HR 11.2).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: